Coiante Scott M

CIK 0001608536

SVP, Chief Financial OfficerDirector

Filings

Latest Mar 3, 2026

Issuers covered

Showing

9 of 9

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Coiante Scott M. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Coiante Scott M has filed

Ticker	Issuer	Filings	Last filed
LXRX	Lexicon Pharmaceuticals, Inc.	4	Mar 3, 2026
APRE	Aprea Therapeutics, Inc.	3	Jun 7, 2022
AGRX	Agile Therapeutics Inc	2	Aug 26, 2024

9 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Mar 3, 2026	LXRXLexicon Pharmaceuticals, Inc.	FTax	54,881	$1.47	$80,675
Feb 17, 2026	LXRXLexicon Pharmaceuticals, Inc.	Holdings only	-	-	-
Feb 18, 2025	LXRXLexicon Pharmaceuticals, Inc.	Holdings only	-	-	-
Jan 2, 2025	LXRXLexicon Pharmaceuticals, Inc.	Holdings only	-	-	-
Aug 26, 2024	AGRXAgile Therapeutics Inc	DDisposition	15,000	$1.52	$22,800
Oct 4, 2023	AGRXAgile Therapeutics Inc	AGrant	20,000	$0.00	$0
Jun 7, 2022	APREAprea Therapeutics, Inc.	FTax	35,284	$0.805	$28,404
Mar 14, 2022	APREAprea Therapeutics, Inc.	AGrant	42,900	$0.00	$0
Mar 1, 2022	APREAprea Therapeutics, Inc.	FTax	14,817	$1.74	$25,782

Showing 1-9 of 9

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.